Login to Your Account



MedImmune's FluMist Vaccine Recommended By FDA Panel

By Kim Coghill


Wednesday, December 18, 2002
By dropping children younger than 5 from its label, MedImmune Inc. was able to convince an FDA panel of experts that the intranasal influenza vaccine FluMist is safe and efficacious in people ages 5 to 49. (BioWorld Today

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription